Teva settles with Oklahoma for $85 million in opioid case | The Times of Israel
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits | InvestorPlace
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Teva agrees to $85 million settlement in opioid public nuisance case
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva, Israel's Biggest Country, In Opioid Legal Trouble
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva_Pharmaceuticals | ערוץ 7
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
